API
< Back to all clusters
[HEALTH] · United States, Hong Kong SAR China · 4 sources

started · updated

Medical studies suggest new benefits for existing blood pressure and bone health drugs

Recent large-scale medical studies have identified potential secondary benefits for common prescription medications.

A study published in The Lancet, led by researchers at Columbia University, suggests that thiazide diuretics may be a more effective first-choice treatment for high blood pressure than ACE inhibitors. By analyzing health records from millions of patients globally, researchers found that those starting with thiazide diuretics experienced fewer serious heart-related issues, particularly heart failure, compared to those using ACE inhibitors. While ACE inhibitors remain valuable for specific conditions, they were linked to a higher risk of side effects such as persistent coughs.

Separately, research from the University of Hong Kong involving over 120,000 patients indicates that nitrogen-containing bisphosphonates (NBPs), a common class of osteoporosis drugs, may reduce the risk of dementia by up to 24 percent. The 15-year study observed that patients aged 60 and older taking these medications developed Alzheimer’s disease at a significantly lower rate than those on other osteoporosis treatments or no medication at all. The findings suggest these drugs could offer dual benefits for aging populations facing both bone loss and cognitive decline.

Entities

Columbia University · The Lancet · University of Hong Kong